Tweets
Toxicity of JAK inhibitors #ACR19 @RheumNow https://t.co/rqy1IfSEyP
Philip Robinson @philipcrobinson ( View Tweet )
6 years 9 months ago
NEW Guidelines for the Management of GCA from #ACR19 in one table
1. Recommend TAB over TA U/S for dx GCA
2. Pts should receive TCZ upfront
3. Don't treat asymptomatic CRP, monitor patients closely
Overall in line with my practice, though I'm pro TA U/S
@RheumNow https://t.co/4mxcqqi1bA
Mike Putman @EBRheum ( View Tweet )
6 years 9 months ago
IL-1 blockade beneficial in MAS. Ferritin to ESR ratio useful for identifying these patients. Cytokines Storm Syndrome is one way of thinking of the spectrum of conditions like MAS, HLH, auto inflammatory disease which respond to IL-1 and IL-6 blockade. Cron R #ACR19 @RheumNow
Dr. Antoni Chan @synovialjoints ( View Tweet )
6 years 9 months ago
Newer JAK inhibitors in development #ACR19 @RheumNow https://t.co/sRIHv7PUyT
Philip Robinson @philipcrobinson ( View Tweet )
6 years 9 months ago
Numerous FOAMed (free open access medical education) options for rheumatology:
- @RheumNow
- @HealioRheum
- @HRheuminations
- @EBRheum
- @RheumJC
- @AWIRGROUP
#ACR19 https://t.co/cnoEWXfozZ
Dr. Paul Sufka @psufka ( View Tweet )
6 years 9 months ago
Virtually every parent of a child with a rheumatic disease uses Facebook to learn about other children with similar health conditions. #ACR19 @rheumnow #Abstr 1756 #ACRBest https://t.co/3L2fQ9vS8X
Jonathan Hausmann MD @hausmannMD ( View Tweet )
6 years 9 months ago
#ACR19 Rheumatology Social Media and the medical professional — @BolekBerqui
Thread ⬇️⬇️⬇️ @RheumNow
Dr. Paul Sufka @psufka ( View Tweet )
6 years 9 months ago
RheumNow's expanded coverage of the #ACR2019 annual meeting is sponsored in part by Novartis. All content chosen by RheumNow and its faculty.
Dr. John Cush @RheumNow ( View Tweet )
6 years 9 months ago
So much JAKi right now - RA, PsA, SLE, and more! Last tweet of the day. Curious to hear...
Which JAKi do you think will win the JAK-wars? @RheumNow
Mike Putman @EBRheum ( View Tweet )
6 years 9 months ago
My favorite social media ninja -- @psufka shares valuable advice for anyone who wants to jump on the #twitter bandwagon.
@cappelliMD joins the party! Distilled + bite-sized information = make the Twittersphere a hit! #ACR19 @RheumNow https://t.co/52und6yfwM
Kanika Monga, MD @DrKanikaMonga ( View Tweet )
6 years 9 months ago
Does anti-TNF treatment halt radiographc progression in ankylosing spondylitis? #ACR19 @RheumNow Vote here 👇
Dr. Antoni Chan @synovialjoints ( View Tweet )
6 years 9 months ago
We start our conversation w/ #SoMe enthusiast @JonathanDauMD ! Twitter truly is an excellent resource during fellowship. #ACR19 @RheumNow https://t.co/lDAL3ubIKC
Kanika Monga, MD @DrKanikaMonga ( View Tweet )
6 years 9 months ago
#ACR19 Poll: What sequence of meds should be used to treat a new case of *severe* seropositive RA? (assume no insurance issues and no comorbidities) @rheumnow
Dr. Paul Sufka @psufka ( View Tweet )
6 years 9 months ago
Do you routinely use TNF inhibitors in your autoimmune patients with preexisting CHF?
Olga Petryna @DrPetryna ( View Tweet )
6 years 9 months ago
Hope to see everyone tomorrow! Abstract #1157 @rheum_cat #ACR19 https://t.co/6zhNv9YZdD
Kanika Monga, MD @DrKanikaMonga ( View Tweet )
6 years 9 months ago
